CTI BioPharma Corp. CTIC was a big mover last session, as the company saw its shares rise roughly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This also led to far more shares changing hands than in a normal session. This continues the uptrend for the company since Jan 23, as the stock is now up over 16%.
The company has not seen any estimate revision in the past 30 days and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
CTI BioPharma currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
A better-ranked med-drugs stock is Auris Medical Holding AG EARS with a Zacks Rank #1 (Strong Buy).
Is CTIC going up? Or down? Predict to see what others think: Up or Down
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment